Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL ANTHRAX VACCINES INDUSTRY
2.1 Summary about Anthrax Vaccines Industry
2.2 Anthrax Vaccines Market Trends
2.2.1 Anthrax Vaccines Production & Consumption Trends
2.2.2 Anthrax Vaccines Demand Structure Trends
2.3 Anthrax Vaccines Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Live Vaccines
4.2.2 Cell free PA Vaccines
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Human Use
4.3.2 Animal Use
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Live Vaccines
5.2.2 Cell free PA Vaccines
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Human Use
5.3.2 Animal Use
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Live Vaccines
6.2.2 Cell free PA Vaccines
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Human Use
6.3.2 Animal Use
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Live Vaccines
7.2.2 Cell free PA Vaccines
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Human Use
7.3.2 Animal Use
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Live Vaccines
8.2.2 Cell free PA Vaccines
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Human Use
8.3.2 Animal Use
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Live Vaccines
9.2.2 Cell free PA Vaccines
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Human Use
9.3.2 Animal Use
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Emergent BioSolutions
10.1.2 Merial
10.1.3 Merck
10.1.4 Zoetis
10.1.5 Bayer Sanidad Animal
10.1.6 Colorado Serum
10.1.7 PharmAthene
10.1.8 Tiankang
10.1.9 Biogénesis-Bago
10.1.10 CAVAC
10.1.11 Rosenbusch
10.1.12 Agrovet
10.1.13 Vecol
10.1.14 CVCRI
10.1.15 IVPM
10.1.16 Prondil
10.1.17 CDV
10.1.18 Indian Immunologicals
10.1.19 Botswana Vaccine Institute
10.1.20 Ceva Santé Animale
10.1.21 Intervac
10.1.22 JOVAC
10.2 Anthrax Vaccines Sales Date of Major Players (2017-2020e)
10.2.1 Emergent BioSolutions
10.2.2 Merial
10.2.3 Merck
10.2.4 Zoetis
10.2.5 Bayer Sanidad Animal
10.2.6 Colorado Serum
10.2.7 PharmAthene
10.2.8 Tiankang
10.2.9 Biogénesis-Bago
10.2.10 CAVAC
10.2.11 Rosenbusch
10.2.12 Agrovet
10.2.13 Vecol
10.2.14 CVCRI
10.2.15 IVPM
10.2.16 Prondil
10.2.17 CDV
10.2.18 Indian Immunologicals
10.2.19 Botswana Vaccine Institute
10.2.20 Ceva Santé Animale
10.2.21 Intervac
10.2.22 JOVAC
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
